William Fanslow

William Fanslow

UNVERIFIED PROFILE

Are you William Fanslow?   Register this Author

Register author
William Fanslow

William Fanslow

Publications by authors named "William Fanslow"

Are you William Fanslow?   Register this Author

16Publications

305Reads

-Profile Views

Intracellular Catabolism of an Antibody Drug Conjugate with a Noncleavable Linker.

Drug Metab Dispos 2015 Sep 22;43(9):1341-4. Epub 2015 Jun 22.

Department of Pharmacokinetics and Drug Metabolism (B.M.R., D.A.R., S.K.P.) and Therapeutic Innovation Unit (K.J.H., M.E.T., W.C.F.), Amgen, Inc., Seattle, Washington

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.115.064253DOI Listing
September 2015

AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.

Invest Ophthalmol Vis Sci 2012 Apr 24;53(4):2170-80. Epub 2012 Apr 24.

Department of Oncology Research, Amgen Inc, Thousand Oaks, California 91320, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1167/iovs.11-7381DOI Listing
April 2012

Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor.

J Immunol 2011 Nov;187(9):4392-402

Immunex Cororation, 51 University Street, Seattle, Washington 98101, USA.

View Article

Download full-text PDF

Source
November 2011

Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors.

Neoplasia 2003 Sep-Oct;5(5):445-56

Department of Cancer Biology and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1502614PMC
July 2004

Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization.

Lab Invest 2003 Nov;83(11):1637-45

Department of Surgery, University of New Mexico School of Medicine, Albuquerque, New Mexico.

View Article

Download full-text PDF

Source
November 2003

Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax.

Blood 2002 Jul;100(1):217-23

Laboratory of Leukocyte Biology,and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, USA.

View Article

Download full-text PDF

Source
July 2002

Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.

J Immunol 2002 Jan;168(2):661-70

Discovery Research Department, Immunex Corporation, Seattle, WA 98101, USA.

View Article

Download full-text PDF

Source
January 2002